Literature DB >> 30228504

Glucocorticoids and Diabetes.

Kevin T Bauerle1, Charles Harris2.   

Abstract

Glucocorticoids (GCs), stress hormones produced by the adrenal gland, are involved in many pathways in physiology and metabolism including glucose homeostasis and inflammation. Excess GC signaling results in Cushing's syndrome and possibly metabolic syndrome. Diabetes, central adiposity, and hyperlipidemia are components of both syndromes. Here, we discuss the mechanisms of GC action, clinical syndromes of GC excess, modulation of glucose homeostasis by GCs, and future treatments for diabetes based on GC signaling.

Entities:  

Year:  2016        PMID: 30228504      PMCID: PMC6139849     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  49 in total

1.  Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

Authors:  F Delaunay; A Khan; A Cintra; B Davani; Z C Ling; A Andersson; C G Ostenson; J Gustafsson; S Efendic; S Okret
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids.

Authors:  S Gremlich; R Roduit; B Thorens
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

Review 3.  Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.

Authors:  Nora Sundahl; Jolien Bridelance; Claude Libert; Karolien De Bosscher; Ilse M Beck
Journal:  Pharmacol Ther       Date:  2015-05-06       Impact factor: 12.310

4.  Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone.

Authors:  Wendy C Bevier; Howard C Zisser; Lois Jovanovic; Daniel A Finan; Cesar C Palerm; Dale E Seborg; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2008-07

5.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

Authors:  F Giorgino; A Almahfouz; L J Goodyear; R J Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

Authors:  J Ruzzin; A S Wagman; J Jensen
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

7.  The use of mifepristone in the treatment of Cushing's syndrome.

Authors:  T Carroll; J W Findling
Journal:  Drugs Today (Barc)       Date:  2012-08       Impact factor: 2.245

Review 8.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

Review 9.  Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.

Authors:  Mi-Jeong Lee; Pornpoj Pramyothin; Kalypso Karastergiou; Susan K Fried
Journal:  Biochim Biophys Acta       Date:  2013-06-02

Review 10.  11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease.

Authors:  Anna Anderson; Brian R Walker
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

View more
  6 in total

Review 1.  Patient-Centered Diabetes Care of Cancer Patients.

Authors:  Anupam Kotwal; Yee-Ming M Cheung; Grace Cromwell; Andjela Drincic; Houry Leblebjian; Zoe Quandt; Robert J Rushakoff; Marie E McDonnell
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

Review 2.  Cancer Biology and Prevention in Diabetes.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

Review 3.  A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus.

Authors:  Tafere Mulaw Belete
Journal:  J Exp Pharmacol       Date:  2020-01-10

4.  Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes.

Authors:  Anthony Aylward; Mei-Lin Okino; Paola Benaglio; Joshua Chiou; Elisha Beebe; Jose Andres Padilla; Sharlene Diep; Kyle J Gaulton
Journal:  PLoS Genet       Date:  2021-05-13       Impact factor: 5.917

5.  Gene cascade analysis in human granulosa tumor cells (KGN) following exposure to high levels of free fatty acids and insulin.

Authors:  Patricia G Tremblay; Chloé Fortin; Marc-André Sirard
Journal:  J Ovarian Res       Date:  2021-12-20       Impact factor: 4.234

6.  Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression.

Authors:  Parker C Wilson; Yoshiharu Muto; Haojia Wu; Anil Karihaloo; Sushrut S Waikar; Benjamin D Humphreys
Journal:  Nat Commun       Date:  2022-09-06       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.